Development of androgen receptor inhibitors and their clinical applications in prostate cancer / 中华泌尿外科杂志

ABSTRACT

In the past two decades, the development and marketing of several novel androgen receptor inhibitors added new options for the treatment of prostate cancer and extended the understanding of the management of prostate cancer. Brief review of the development history and the key aspects of these inhibitors will be conducive to individualised therapy, and further improve patient survival and other clinical benefits.